Terms: = Bone cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269
56 results:
1. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b/hoxa9.
Yao Q; Zhang L; Liu Z; Yu L; Wang Y; Liu J; Wang Y
Environ Sci Pollut Res Int; 2023 Feb; 30(7):19250-19258. PubMed ID: 36229729
[TBL] [Abstract] [Full Text] [Related]
3. Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
Roux B; Picou F; Debeissat C; Koubi M; Gallay N; Hirsch P; Ravalet N; Béné MC; Maigre M; Hunault M; Mosser J; Etcheverry A; Gyan E; Delhommeau F; Domenech J; Herault O
Cancer Gene Ther; 2022 Aug; 29(8-9):1263-1275. PubMed ID: 35194200
[TBL] [Abstract] [Full Text] [Related]
4. DOT1L inhibitors block abnormal self-renewal induced by cohesin loss.
Heimbruch KE; Fisher JB; Stelloh CT; Phillips E; Reimer MH; Wargolet AJ; Meyer AE; Pulakanti K; Viny AD; Loppnow JJ; Levine RL; Pulikkan JA; Zhu N; Rao S
Sci Rep; 2021 Mar; 11(1):7288. PubMed ID: 33790356
[TBL] [Abstract] [Full Text] [Related]
5. Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.
Chang KC; Chen RY; Wang YC; Hung LY; Medeiros LJ; Chen YP; Chen TY; Yang JC; Chiang PM
Sci Rep; 2020 Dec; 10(1):21342. PubMed ID: 33288848
[TBL] [Abstract] [Full Text] [Related]
6. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
[TBL] [Abstract] [Full Text] [Related]
7. An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in
Wang H; Shah CA; Hu L; Huang W; Platanias LC; Eklund EA
J Biol Chem; 2020 Jul; 295(28):9663-9675. PubMed ID: 32467231
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.
Wang JD; Zhou HS; Tu XX; He Y; Liu QF; Liu Q; Long ZJ
Aging (Albany NY); 2019 May; 11(10):3333-3347. PubMed ID: 31164492
[TBL] [Abstract] [Full Text] [Related]
9. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes.
Bell D; Bell AH; Kupferman ME; Prieto VG; Weber RS; Hanna EY
Head Neck; 2019 Sep; 41(9):3090-3104. PubMed ID: 31041828
[TBL] [Abstract] [Full Text] [Related]
10. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA‑873 targets hoxa9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
Int J Oncol; 2019 May; 54(5):1809-1820. PubMed ID: 30816476
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-1294 targets hoxa9 and has a tumor suppressive role in osteosarcoma.
Zhang ZF; Li GR; Cao CN; Xu Q; Wang GD; Jiang XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8582-8588. PubMed ID: 30575897
[TBL] [Abstract] [Full Text] [Related]
13.
Trissal MC; Wong TN; Yao JC; Ramaswamy R; Kuo I; Baty J; Sun Y; Jih G; Parikh N; Berrien-Elliott MM; Fehniger TA; Ley TJ; Maillard I; Reddy PR; Link DC
Cancer Res; 2018 Jul; 78(13):3510-3521. PubMed ID: 29724719
[TBL] [Abstract] [Full Text] [Related]
14. hoxa9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
de Bock CE; Demeyer S; Degryse S; Verbeke D; Sweron B; Gielen O; Vandepoel R; Vicente C; Vanden Bempt M; Dagklis A; Geerdens E; Bornschein S; Gijsbers R; Soulier J; Meijerink JP; Heinäniemi M; Teppo S; Bouvy-Liivrand M; Lohi O; Radaelli E; Cools J
Cancer Discov; 2018 May; 8(5):616-631. PubMed ID: 29496663
[TBL] [Abstract] [Full Text] [Related]
15. Derepression of the Iroquois Homeodomain Transcription Factor Gene IRX3 Confers Differentiation Block in Acute Leukemia.
Somerville TDD; Simeoni F; Chadwick JA; Williams EL; Spencer GJ; Boros K; Wirth C; Tholouli E; Byers RJ; Somervaille TCP
Cell Rep; 2018 Jan; 22(3):638-652. PubMed ID: 29346763
[TBL] [Abstract] [Full Text] [Related]
16. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA
Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638
[TBL] [Abstract] [Full Text] [Related]
17. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
[TBL] [Abstract] [Full Text] [Related]
18. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
[TBL] [Abstract] [Full Text] [Related]
19. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.
Yokoyama T; Nakatake M; Kuwata T; Couzinet A; Goitsuka R; Tsutsumi S; Aburatani H; Valk PJ; Delwel R; Nakamura T
J Clin Invest; 2016 May; 126(5):1664-78. PubMed ID: 27018596
[TBL] [Abstract] [Full Text] [Related]
20. Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance.
Vukovic M; Guitart AV; Sepulveda C; Villacreces A; O'Duibhir E; Panagopoulou TI; Ivens A; Menendez-Gonzalez J; Iglesias JM; Allen L; Glykofrydis F; Subramani C; Armesilla-Diaz A; Post AE; Schaak K; Gezer D; So CW; Holyoake TL; Wood A; O'Carroll D; Ratcliffe PJ; Kranc KR
J Exp Med; 2015 Dec; 212(13):2223-34. PubMed ID: 26642852
[TBL] [Abstract] [Full Text] [Related]
[Next]
